SLG
MRSN icon

Stanley-Laman Group’s Mersana Therapeutics MRSN Stock Holding History

Stanley-Laman Group’s Portfolio MRSN Stock Details MRSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-710
Closed -$280K – 270
2018
Q1 		$280K Buy
+710
New +$280K 0.06% 242